Using polygenic scores for identifying individuals at increased risk of substance use disorders in clinical and population samples.
Barr PB, Ksinan A, Su J, Johnson EC, Meyers JL, Wetherill L, Latvala A, Aliev F, Chan G, Kuperman S, Nurnberger J, Kamarajan C, Anokhin A, Agrawal A, Rose RJ, Edenberg HJ, Schuckit M, Kaprio J, Dick DM.
Barr PB, et al.
Transl Psychiatry. 2020 Jun 18;10(1):196. doi: 10.1038/s41398-020-00865-8.
Transl Psychiatry. 2020.
PMID: 32555147
Free PMC article.